Sanjog Ramdharane 1, Dr. Vinay Gaitonde 2

Similar documents
International Journal of Pharma and Bio Sciences

International Journal of Pharma and Bio Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET

Development and validation of related substances method for Varenicline and its impurities

Pelagia Research Library

Available online at Scholars Research Library

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Development and Validation of RP-HPLC Method for the Estimation of Gemigliptin

J Pharm Sci Bioscientific Res (4): ISSN NO

Journal of Chemical and Pharmaceutical Research

Pelagia Research Library

Asian Journal of Chemistry Vol. 21, No. 1 (2009),

ANALYTICAL TECHNIQUES FOR THE QUALITY OF ANTI- AIDS DRUGS

Tentu Nageswara Rao et al. / Int. Res J Pharm. App Sci., 2012; 2(4): 35-40

METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

ISSN (Print)

Available online Research Article

Development and Validation of a Simultaneous HPLC Method for Quantification of Amlodipine Besylate and Metoprolol Tartrate in Tablets

Pankti M. Shah et al, Asian Journal of Pharmaceutical Technology & Innovation, 04 (17); 2016; 07-16

Scholars Research Library. Der Pharmacia Lettre, 2015, 7 (5):44-49 (

Journal of Chemical and Pharmaceutical Research

Development and validation of RP-HPLC method for simultaneous estimation of gliclazide and metformin in pure and tablet dosage form

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS OF TRAMADOL IN PURE AND PHARMACEUTICAL FORMULATIONS

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

A Validated Stability Indicating RP-HPLC Method for Simultaneous Estimation of Valsartan and Clinidipine Combined Tablet dosage forms

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

Journal of Chemical and Pharmaceutical Research, 2017, 9(9): Research Article

36 J App Pharm Vol. 6; Issue 1: 36-42; January, 2014 Rao et al., 2014

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

CHAPTER 2 SIMULTANEOUS DETRMINATION OF ANASTROZOLE AND TEMOZOLOMIDE TEMOZOLOMIDE CAPSULES 20 MG AND ANASTROZOLE TABLETS 1 MG

World Journal of Pharmaceutical Research

A New Stability-Indicating and Validated RP-HPLC Method for the Estimation of Liraglutide in Bulk and Pharmaceutical Dosage Forms

Development and Validation of Area Under Curve Method for Simultaneous Estimation of Thiocolchicoside and Lornoxicam in Tablet Dosage Form

Stability indicating RP-HPLC method development and validation of Etizolam and Propranolol hydrochloride in pharmaceutical dosage form

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

Ankit et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), Available online at RESEARCH ARTICLE

Volume 2 (6), 2014, Page CODEN (USA)-IJPRUR, e-issn: International Journal of Pharma Research and Health Sciences

Research Article Simultaneous Estimation of DL-Methionine and Pyridoxine Hydrochloride in Tablet Dosage Form by RP-HPLC

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

Simple and stability indicating RP-HPLC assay method development and validation lisinopril dihydrate by RP-HPLC in bulk and dosage form

Volume 6, Issue 1, January February 2011; Article-021

Estimation of zolmitriptan by a new RP-HPLC method

Corresponding Author:

HPTLC Determination of Atomoxetine Hydrochloride from its Bulk Drug and Pharmaceutical Preparations

Reverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms

(ACE) inhibitor class that is primarily used in cardiovascular. conditions. Lisinopril was introduced into therapy in the early

AMERICAN JOURNAL OF BIOLOGICAL AND PHARMACEUTICAL RESEARCH

Pelagia Research Library

Scholars Research Library. Der Pharmacia Lettre, 2016, 8 (6): (

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

New RP-HPLC Method for the Determination of Fludarabine in Pharmaceutical Dosage Forms

Development of a Validated RP-HPLC Method for the Analysis of Citicoline Sodium in Pharmaceutical Dosage Form using Internal Standard Method

REVERSE PHASE HPLC METHOD FOR THE ANALYSIS OF ALFUZOSIN HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORMS

USP purity analysis of pravastatin sodium using the Agilent 1120 Compact LC

A HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR LERCANIDIPINE HYDROCHLORIDE

A stability indicating RP-HPLC method for simultaneous estimation of darunavir and cobicistat in bulk and tablet dosage form

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ETORICOXIB AND THIOCOLCHICOSIDE IN PHARMACEUTICAL DOSAGE FORMS

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

International Journal of Medicine and Pharmaceutical Research. International Journal of Medicine and Pharmaceutical Research

A simple validated RP-HPLC method for quantification of sumatriptan succinate in bulk and pharmaceutical dosage form

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

International Journal of Drug Research and Technology

Scholars Research Library

Dhull Rohit, Kumar Sanjay, Jalwal Pawan Department of Chemistry, OPJS Churu, Rajasthan, India

International Journal of Drug Research and Technology

Abstract. G. D. Patil 1, P. G. Yeole 1, Manisha Puranik 1 and S. J. Wadher 1 *

Analytical Method Development and Validation for the Estimation of Imatinib Mesylate and its Impurity in Pharmaceutical Formulation by RP-HPLC

Research Article DEVOLOPMENT OF RP-HPLC METHOD AND IT S VALIDATION FOR SIMULTANEOUS ESTIMATION OF SITAGLIPTIN AND METFORMIN

New RP - HPLC Method for the Determination of Valproic acid in Human Plasma

S. G. Talele, D. V. Derle. Department of Pharmaceutics, N.D.M.V.P. College of Pharmacy, Nashik, Maharashtra, India

NOVEL RP-HPLC METHOD. B.Lakshmi et a. concentration range KEY INTRODUCTION. Diltiazem is used to. . It works by of contractionn of the. (dilate).

Validation of Developed Analytical Method for Balofloxacin Floating Tablets by Reverse Phase High Performance Liquid Chromatography

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

Stress Degradation Studies And Validation Method For Quantification Of Aprepitent In Formulations By Using RP-HPLC

VALIDATED RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DEXAMETHASONE AND GRANISETRON IN COMBINED DOSAGE FORMS

CHAPTER-5. Sumatriptan Succinate

DEVELOPMENT OF RP-HPLC METHOD FOR ESTIMATION OF DROTAVERINE HYDROCHLORIDE IN PHARMACEUTICAL FORMULATIONS

ESTIMATION OF RELATED SUBSTANCES OF FEBUXOSTAT IN BULK & 40/80/120mg TABLETS BY RP-HPLC

Simultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by RP-HPLC method

SIMULTANEOUS DETERMINATION OF ATORVASTATIN AND EZETIMIBE BY RP-HPLC IN PURE AND PHARMACEUTICAL DOSAGE FORM

RP- HPLC and Visible Spectrophotometric methods for the Estimation of Meropenem in Pure and Pharmaceutical Formulations

SIMULTANEOUS ESTIMATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN TABLETS BY RP-HPLC METHOD

Int. Res J Pharm. App Sci., 2012; 2(3):22-28

Int. J. Pharm. Sci. Rev. Res., 24(2), Jan Feb 2014; nᵒ 18,

A stability-indicating LC method for the assay estimation of itraconazole in pharmaceutical dosage form

Scholars Research Library

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

Method Development and Validation for the Estimation of Saroglitazar in Bulk and Pharmaceutical Dosage Form by RP-HPLC

Journal of Chemical and Pharmaceutical Research

Estimation of Etoricoxib in Tablet Dosage form by RP- HPLC using Internal Standard with Emphasize on Specificity Parameter Method

A Validated Chiral Liquid Chromatographic Method for The Enantiomeric Separation of Dapoxetine Hydrochloride

Stability indicating RP-HPLC method for simultaneous determination of Beclomethasone Dipropionate and Clotrimazole from dosage form

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ASSAY AND DISSOLUTION OF METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS

Development and Validation of RP-HPLC Method for the Determination of Adefovir Dipivoxil in Bulk and in Pharmaceutical Formulation

Transcription:

JPSBR: Volume 5, Issue 2: 2015 (151-155) ISS. 2271-3681 A ew Gradient RP- HPLC Method for Quantitative Analysis of : (3-luoro-4- Morpholin-4-yl-Phenyl)-Carbamic Acid Methyl Ester and its Related Substances ABSTRACT: Sanjog Ramdharane 1, Dr. Vinay Gaitonde 2 1 Research scholar, JJT University, Jhunjhunu, Rajasthan, India 2 PhD. Guide, JJT University, Jhunjhunu, Rajasthan, India The present research describes a validated and novel RP-HPLC method for the quantitative analysis of (3-fluoro-4-morpholin-4-ylphenyl)-carbamic acid methyl ester and its two related substances in KSM (Key Starting material). The chromatographic separation was achieved on a C18 stationary phase with a gradient mobile phase prepared from methanol and phosphate buffer. The quantification was carried out by UV detection at 250 nm. The developed RP-LC method was validated according to ICH guidelines. The percent recovery for individual substances at 25, 50, 100 and 150% of specification concentrations were found to be between 95 to 105% Indicating the accuracy of the method. The %RSD for system precision was found to be less than 2.0. The %R.S.D for repeatability and intermediate precision for the process-related impurities in (3-fluoro-4-morpholin-4-yl-phenyl)- carbamic acid methyl ester were found to be less than 1.0. The correlation coefficient of (3-fluoro-4-morpholin-4-yl-phenyl)- carbamic acid methyl ester and its two related substances was found to be greater than 0.99. The developed LC method can be used for the quantitative determination of (3-fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester and its two related substances in KSM. KEY WRDS: (3-fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester, ICH guidelines, Validation, RP-HPLC, KSM Article history: Received 7 Dec 2014 Revised 17 Jan 2015 Accepted 25 jan 2015 Available online 01 March 2015 Citation: Ramdharane S, Gaitonde V. A ew Gradient RP- HPLC Method for Quantitative Analysis of : (3-luoro-4-Morpholin-4-yl- Phenyl)-Carbamic Acid Methyl Ester and its Related Substances. J Pharm Sci Bioscientific Res. 2015 5(2):151-155 ITRDUCTI: (3-fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester is KSM (Key Starting material) is used to synthesis the Linezolid API in one of route of synthesis. The Route of synthesis of (3-fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester is as below. + - + 3,4-Diflouro nitro benzene H Morpholine DM/K2C3 itro impurity Reduction Pd/C H 2 impurity or Correspondence: Mr. Sanjog Ramdharane Research scholar, JJT University, Jhunjhunu, Rajasthan, India Email: sanjogramdharane@gmail.com (www.jpsbr.org) Methyl Chloroformate H +- (3-louro-4-morpholin-4-yl-phenyl)- carbamic acid methyl ester igure 1: Reaction scheme 1 Ramdharane S et al 151

JPSBR: Volume 5, Issue 2: 2015 (151-155) ISS. 2271-3681 During the manufacturing of (3-fluoro-4-morpholin-4-ylphenyl)-carbamic acid methyl ester little amount of impurities are always carried in to final Product. Two possible impurity identify for method development. ame of these two impurities are itro impurity and impurity. Both impurities Structure are in above reaction scheme. However there is no reported LC method by an exhaustive computer- Assisted literature survey method was validated according to ICH guidelines. Here we describe the investigation in detail. The Liquid Chromatographic system consisted of quaternary gradient pump, 25 C, column oven and a UV detector. The output signal was monitored and integrated using LC solutions chromatography manager software (Prominence HPLC, Shimadzu, Japan). MATERIALS AD METHDS Chemicals and Reagents Samples of (3-fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester and its related impurities itro impurity and impurity were procured from Venkar Chemicals Private Limited Hyderabad. HPLC grade Methanol and analytical Potassium dihydragen Phosphate was obtained from Merck.(Mumbai, India). High purity water was prepared by Millipore Milli-Q plus purification system (Millipore, Bedford, USA). was weighed accurately and transferred into 50 ml standard volumetric flask. It was dissolved in sufficient quantity of diluent and made up to the mark with the same diluent. Preparation of impurity mixture. About 5.0mg of each (3-fluoro-4-morpholin-4-yl-phenyl)- carbamic acid methyl ester related impurities viz: itro impurity and impurity and (3-fluoro-4-morpholin-4-ylphenyl)-carbamic acid were weighed accurately and transferred to 10 ml standard volumetric flask. and dissolved in diluent and made up to the mark. 1.0 ml of this solution was diluted to 100mL with diluent.1.0ml of this solution further diluted to 10 ml with diluent. (i.e. 0.1% of each impurity with respect to (3-fluoro-4-morpholin-4-yl-phenyl)- carbamic acid methyl ester at the concentration of 0.5mg/mL and injected in to the system. Method Validation [2-8] Specificity study The specificity of the developed LC method for related substances of (3-fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester was evaluated by Injecting (3-fluoro-4- morpholin-4-yl-phenyl)-carbamic acid methyl ester, impurity and itro separately for retention time confirmation. Retention time table-1 is as below. Table -1: Retention time table Equipment Chromatographic conditions ame impurity Retention Time About 7.2 min The chromatographic column used was ProntoSil 120-5-C18- ace-eps, 250 x 4.6 mm, 5μm particle. Mobile phase consisted of A and B. Mobile phase A was 20 Mm potassium dihydrogen. This solution was filtered through 0.45 μm nylon filter. Mobile phase B used was HPLC grade Methanol. Theflow rate of the mobile phase was as per Gradient program. The gradient program applied is shown in Table 1. The sample injection volumewas 20 μl and the quantification were achieved by UV detector at 250nm. Diluent A mixture of mobile phase A and methanol in the ratio of 50:50 V/V was used as diluent. The above solution was filtered through a 0.45μ nylon membrane filter prior to use. Preparation of test solution: About 25.0mg of (3-fluoro-4- morpholin-4-yl-phenyl)-carbamic acid methyl ester sample itro impurity (3-fluoro-4-morpholin-4-ylphenyl)-carbamic acid methyl ester Linearity About 19.3 min About 13.5 min Standard solutions at nine different concentration levels ranging from LQ to 0.15μg/mL (150% of specification limit) were prepared and analyzed in duplicate to demonstrate the linearity for (3-fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester and two four impurities. The calibration curves were plotted for two impurities using area counts versus corresponding concentrations. The slope, Y-intercept and correlation coefficient were calculated. The response factors were Ramdharane S et al 152

JPSBR: Volume 5, Issue 2: 2015 (151-155) ISS. 2271-3681 calculated by comparing the slope of the calibration curve for the impurities ( impurity and itro impurity ) with that of the (3-fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester The related substances were quantified against area count of respective impurity in standard solution. Accuracy Accuracy of the method was demonstrated by using (3-fluoro- 4-morpholin-4-yl-phenyl)-carbamic acid methyl ester spiked with a related impurities at four different concentration levels in triplicate. The analyses were carried out at 25%, 50%, 100% and 150% of specification limit as per ICH guidelines. The mean recoveries of all the impurities were calculated. Precision System precision of the method was evaluated by injecting (3- fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester standard solution six times and calculated the percent relative standard deviation (%RSD) for area of (3-fluoro-4-morpholin- 4-yl-phenyl)-carbamic acid methyl ester peak. The precision of the method for the determination of impurities related to (3- fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester, was studied for repeatability and intermediate precision. Repeatability was demonstrated by analyzing the synthetic homogeneous solution containing 0.1 % of each impurity spiked to (3-fluoro-4-morpholin-4-yl-phenyl) carbamic acid methyl ester sample for six times. The %RSD for peak area of each impurity was calculated. Intermediate precision of the method was demonstrated by analyzing same sample of (3- fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester on three different days (inter day) and intra-day variations of impurities of (3-fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester are expressed in terms of %R.S.D values. Limit of detection (LD) and Limit of quantitation (LQ) The limit of detection and limit of quantitation for (3-fluoro-4- morpholin-4-yl-phenyl)-carbamic acid methyl ester, impurity and itro impurity were calculated from the linearity data using residual standard deviation of the response and slope of the calibration curve for each impurity Precision LQ level Precision of the method was also evaluated by injecting standard solutions of impurity and itro impurity at about the predicted LQ levels for six times separately and calculated the percent relative standard deviations (%RSD) for area of each impurity peak. Robustness In order to demonstrate the robustness of the method, system suitability parameters were verified by making deliberate changes in the chromatographic conditions, viz. change in flow rate by ±0.1 ml/ min, and change in the column temperature by ±3 C, keeping the rest of the chromatographic conditions for each alteration study constant. RESULTS AD DISCUSSI Initial separation experiments The main aim of the chromatographic method is to separate (3-fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester and its two related impurities in the product. Different reverse phase stationary phase were employed during method development and different kind of mobile phase with different ph condition were studied with combination of Methanol. The resolution The gradient program was optimized in order to elute both impurities and (3-fluoro-4-morpholin-4-ylphenyl)-carbamic acid methyl ester. chromatographic separation of all the impurities was achieved successfully by following the gradient program tabulated in Table -2 using the mobile phase as mentioned under the experimental section. Table 2: Gradient programme: Time in min low rate (ml/min) Mobile phase-a (%) Mobile phase-b (%) 0.0 1.00 75 25 6.0 1.00 75 25 20.0 1.00 25 75 21.0 1.00 75 25 25.0 1.00 75 25 The typical retention times of (3-fluoro-4-morpholin-4-ylphenyl)-carbamic acid methyl ester, impurity and itro are about 7.3, 14.1 and 19.6 min, respectively. Standard chromatogram of (3-fluoro-4- morpholin-4-yl-phenyl)-carbamic acid methyl ester, impurity and itro (0.5µg/mL) is shown in ig.2. A typical chromatogram of (3-fluoro-4-morpholin-4-yl-phenyl)- carbamic acid methyl ester sample is also shown in (ig. 3). It is clear that all the compounds were eluted and separated with good peak shapes and resolution. Ramdharane S et al 153

JPSBR: Volume 5, Issue 2: 2015 (151-155) ISS. 2271-3681 Limit of detection (LD) and Limit of quantitation (LQ) LD values were found to be 0.009, 0.033, μg/ml for impurities impurity and itro impurity respectively. LQ values were found to be 0.021, 0.05 μg/ml for impurity and itro impurity respectively (Table 3) Table 4: Precision studies for impurities at LQ level. Substance LQ level Mean peak area %RSD (n=6) igure. 2: HPLC Chromatogram showing (0.5µg/mL) of standard solution of (3-fluoro-4-morpholin-4-yl-phenyl)- carbamic acid methyl ester, impurity and itro Mean* peak area 1073 3.6 itro 510 4.6 * Average of six determinations Precision at LQ level Precision of the method was also checked at about predicted level of LQ. The %R.S.Ds for each impurity was shown in Table 4. Precision igure 3 HPLC Chromatogram showing (0.5mg/mL) of standard solution of (3-fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester Method Validation Specificity study Table -1 clearing indicating that the method is specific and able to resolve all the process-related impurities. Linearity The linearity regression analysis was demonstrated to check the acceptability of the method for quantitative determination range of LQ to 150% of the specification limit. The coefficient of correlation was found to be more than 0.9997. The values of slope, intercept, correlation coefficient, LD and LQ for each impurity were shown in Table 3. Substance Table 3: Summary of linearity, LD and LQ Correlation coefficient LD (μg/ml) LQ (μg/ml) Accuracy The percent recovery for individual substances at 25, 50, 100 and 150% of specification concentrations for impurity and 50, 100 and 150% of specification concentrations for itro impurity. (Table 5) were found to be between 95 to 105% indicating the accuracy of the method. Table 5: Parameters of recovery of impurities of (3-fluoro-4- morpholin-4-yl-phenyl)-carbamic acid methyl ester ame Spike level % Recovery * 25 91 50 96 100 102 150 104 itro 50 93 itro 0.9997 0.009 0.021 0.9995 0.033 0.05 itro 100 98 itro 150 101 * Average of three determinations Ramdharane S et al 154

JPSBR: Volume 5, Issue 2: 2015 (151-155) ISS. 2271-3681 Table 6: Precision studies for (3-fluoro-4-morpholin-4-ylphenyl)-carbamic acid methyl ester and its impurities Substance itro Precision Method precision Intermediate precision Intraday 0.56 0.43 0.52 0.83 0.73 0.87 Inter day The %RSD for system precision was found to be less than 2.0. The precision of the method for the determination of impurities related to (3-fluoro-4-morpholin-4-yl-phenyl)- carbamic acid methyl ester sample.repeatability and intermediate precision for impurities in (3-fluoro-4- morpholin-4-yl-phenyl)-carbamic acid methyl ester were found to be less than 1.0 %R.S.D. The results are presented under Table 6, which confirm good precision of the method. Robustness The method was demonstrated to be robust over an acceptable working range of its HPLC operational conditions. The system suitability results within the acceptable limits and selectivity of individual substances were also not affected when subjected deliberately for varied chromatographic conditions. The result of the study confirms the robustness of the method. ACKWLEDGEMETS We are very thankful to Venkar Chemicals Private Limited Hyderabad, India for providing standards sample of (3-fluoro- 4-morpholin-4-yl-phenyl)-carbamic acid methyl ester and its impurities and also for providing the necessary facilities and constant encouragement. REERECES: 1. Barbachyn M R, Brickner S J, Hutchinson D. Substituted oxazine and thiazine oxazolidinone antimicrobials K. Patent no. EP 0717738B1 2. ICH, Q2B (2005) Validation of Analytical Procedure: Methodology, International Conference on Harmonization, IPMA, Geneva, Switzerland. 3. DA, ICH-Q1A (R2): Stability Testing of ew Drug Substances And Product, Vol. 68, U S ood and Drug Administration, Washington, DC, USA, 2nd edition 2003. 4. DA, ICH-Q1B: Photo-stability Testing of ew Drug Substance and Product, Vol. 62, U S ood and Drug Administration Washington, DC, USA, 1997. 5. DA, ICH-Q2 (R1): Validation of analytical Procedures: Text and Methodology, Vol. 60, US ood and Drug Administration, Washington, DC, USA, 1995. 6. United State Pharmacopoeia 30 ational ormulary 25, The U.S. Pharmacopoeia Convention, United State CCLUSI The validated RP- LC method developed for the quantification of (3-fluoro-4-morpholin-4-yl-phenyl)-carbamic acid methyl ester and its related substances in Product was reported. The method was found to be selective, sensitive, precise and accurate. The developed RP- LC method showed satisfactory results for all tested method validation parameters. The formulated method can be used for assessing the impurities in the drug substance. The developed method can be conveniently used by quality control departments to determine the related substance and in regular production samples of this intermediate. Ramdharane S et al 155